Annual report pursuant to Section 13 and 15(d)

Deferred Revenue (Details Narrative)

v3.7.0.1
Deferred Revenue (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Aug. 31, 2016
Nov. 30, 2015
May 31, 2015
Dec. 31, 2015
Dec. 31, 2016
Dec. 31, 2015
Deferred Revenue Arrangement [Line Items]            
Deferred revenue     $ 1,250,000   $ 4,500,000  
Grants receivable       1,000,000
Revenue         1,911,424 $ 648,382
Cystic Fibrosis Foundation Therapeutics Inc [Member]            
Deferred Revenue Arrangement [Line Items]            
Deferred revenue         500,000  
Amount received upon execution of award agreement $ 1,000,000 $ 1,250,000 $ 1,250,000 $ 1,250,000 $ 500,000